Grazia D'Onofrio

Medicine & Life Sciences

1. Alzheimer Disease 100%
2. Dementia 48%
3. Cognitive Dysfunction 41%
4. Vascular Dementia 31%
5. Apolipoproteins E 29%
6. Geriatric Assessment 26%
7. Serotonin Plasma Membrane Transport Proteins 24%
8. Elderly 23%
9. Activities of Daily Living 23%
10. Cytochrome P-450 CYP2D6 22%
11. Genotype 21%
12. Genes 20%
13. Frailty 18%
14. Depression 17%
15. Donepezil 16%
16. Major Depressive Disorder 16%
17. Mortality 15%
18. Systematic Reviews 15%
19. bapineuzumab 15%
20. Information Technology 13%
21. Technology 13%
22. Amyloid 13%
23. Robotics 12%
24. Cholinesterase Inhibitors 11%
25. Delusions 11%
26. Caregivers 10%
27. Biomarkers 10%
28. Geriatrics 10%
29. Communication 10%
30. Amyloid Precursor Protein Secretases 9%
31. Nutrition Assessment 9%
32. Haplotypes 9%
33. Brain 9%
34. Therapeutics 9%
35. Cytochromes 8%
36. Neurodegenerative Diseases 8%
37. Neuroprotective Agents 8%
38. Serotonin Uptake Inhibitors 8%
39. Peptidyl-Dipeptidase A 8%
40. Metabolic Syndrome 7%
41. Alleles 7%
42. Quality of Life 7%
43. Socialization 6%
44. Rivastigmine 6%
45. Longitudinal Studies 6%
46. Mental Status and Dementia Tests 6%
47. Serotonin 6%
48. Neurocognitive Disorders 6%
49. Endophenotypes 6%
50. Single Nucleotide Polymorphism 6%